Women's Health

Preventing cervical cancer: HPV vaccination and screening both matter

Persistent high-risk HPV causes most cervical cancers. Vaccination reduces risk, while screening can find precancerous change early.

Illustration of a woman discussing cervical screening and HPV prevention
Illustrative image

How prevention works

HPV is common and usually clears, but persistent high-risk infection can cause precancerous cervical changes. Vaccination protects against important HPV types before future exposure.

Dose schedules depend on age at the first dose and immune status. Ask for a catch-up plan rather than restarting without advice.

What screening can find

A Pap test examines cervical cells; an HPV test looks for high-risk virus types. The test and interval depend on age, past results, treatment and immune status.

An abnormal result usually means follow-up is needed—not that cancer has been diagnosed.

Symptoms should not wait

Screening is for people without symptoms. Bleeding after intercourse, between periods or after menopause, persistent watery or blood-stained discharge and pelvic pain need evaluation.

After hysterectomy, screening depends on why surgery was performed and whether the cervix was removed.

Who needs cervical screening?

Screening is designed for people without symptoms and follows age- and history-based intervals. The appropriate test may be HPV testing, cervical cytology or a combination, depending on local guidance and previous results. People treated for cervical precancer, living with immune suppression or exposed to certain risks may need a different schedule.

Vaccination reduces future HPV-related disease but does not protect against every cancer-causing type and does not treat an existing infection. Vaccinated people therefore continue recommended screening. After hysterectomy, the need depends on whether the cervix remains and whether surgery or earlier treatment involved cervical precancer or cancer.

What happens after an abnormal result?

An abnormal HPV or Pap result is not a cancer diagnosis. Some results lead to repeat testing after an interval; others require colposcopy, where the cervix is examined closely and a small biopsy may be taken. The plan reflects HPV type, cell changes, age, pregnancy and previous screening history.

Following up matters because precancerous changes can often be treated before invasive cancer develops. Keep copies of reports so future clinicians can see the complete sequence. Symptoms such as bleeding after intercourse, bleeding after menopause or persistent unusual discharge need examination even when the last screening test was normal.

Making HPV vaccination and screening easier

Keep a record of vaccine dates and cervical test results instead of relying on memory. If a vaccine course is interrupted, ask whether it can be continued rather than assuming it must restart. Before screening, mention pregnancy, bleeding, previous cervical treatment and immune conditions. A respectful examination should include consent, privacy and an explanation of what is happening; anxiety or previous trauma can be discussed so the visit can be adapted.

Frequently asked questions

Questions patients commonly ask

Do I still need cervical screening after HPV vaccination?

Yes. Vaccination greatly reduces risk from important HPV types but does not cover every cause of cervical cancer and does not replace screening.

Does a positive HPV test mean my partner was recently unfaithful?

No. HPV can remain undetected for years, so a positive result usually cannot show when infection occurred or from whom it was acquired.

Is an abnormal Pap test the same as cancer?

No. Most abnormal results represent HPV infection or cell changes that require monitoring or treatment. Follow-up determines whether precancer is present.

Clinical references

This guide is informed by patient guidance from established public-health and professional medical bodies.